Business Wire

Marc Benioff and Jim Cramer Supported XPRIZE Next-Gen Mask Challenge Records Massive Participation

3.10.2020 04:08:00 EEST | Business Wire | Press release

Share

XPRIZE today announced that the million dollar Next-Gen Mask Challenge received record-breaking team entry numbers in their newest initiative that called upon young innovators from around the world ages 15 to 24 to reimagine protective face masks. By limiting participation to youth participants, XPRIZE aimed to galvanize the next generation of innovators, and the overwhelming response demonstrated the eagerness of Gen-Z creators to make an impact on the world.

Within 60 days, the XPRIZE Next-Gen Mask Challenge received 992 interested participants, making it the largest, most prolific call-to-action in XPRIZE Foundation history. Potential teams originated from 76 countries, proof of the global desire to overcome many of the common barriers associated with traditional protective masks.

“We understand that masks can be ill-fitting, uncomfortable, unfashionable, and that the most effective masks are often unavailable or expensive for everyday people. We need an alternative, that’s why XPRIZE is turning to the world’s young innovators to help reinvent the face mask and create an accessible alternative that will help protect against the spread of COVID-19,” said Peter H. Diamandis, XPRIZE founder and executive chairman. “We’re going to take the top 25 designs and find out if they’re manufacturable. Once we determine their manufacturability, we’re going to take the top 10 of those and go out to influencers to gauge acceptance.”

XPRIZE, a nonprofit organization that uses global competitions to crowdsource solutions to some of the world’s biggest challenges, recognized that currently one-third of the US population doesn’t regularly wear a mask, despite evidence showing that when used properly they can significantly reduce transmission of viruses. The $1M XPRIZE Next-Gen Mask Challenge contest, sponsored by Marc Benioff and Jim Cramer, will award the grand prize to young innovators whose mask design best combines ingenuity, effectiveness, X-factor of style, and ability to overcome common barriers to use as measured by a pre-Challenge poll taken by over 3,000 participants.

“There is a gigantic amount of evidence that masks can stop the spread,” said Jim Cramer, the host of Mad Money on CNBC. “I’m so proud to sponsor the XPRIZE Next-Gen Mask Challenge with Marc Benioff, it's amazing how resourceful people are when you ask them to design a mask that those who object to most masks might even wear.”

“If everyone in the United States wore a mask for 3 weeks — just 3 weeks — we would not have anymore coronavirus, because there would be no more spread, but people do not want to wear masks,” said sponsor Marc Benioff.

XPRIZE’s Next-Gen Mask Challenge will culminate in a final judging event, with in-lab testing this October supported by partners 3M and Honeywell and winners will be announced later this year. Additional details and the list of teams moving forward can be found here.

ABOUT XPRIZE

XPRIZE, a 501(c)(3) nonprofit, is the global leader in designing and implementing innovative competition models to solve the world’s grandest challenges. Active competitions include the $20 Million NRG COSIA Carbon XPRIZE, the $10 Million Rainforest XPRIZE, the $10 Million ANA Avatar XPRIZE, the $5 Million IBM Watson AI XPRIZE, $5 Million XPRIZE Rapid Reskilling, XPRIZE NextGen Mask Challenge and $5 Million XPRIZE Rapid COVID Testing. For more information, visit xprize.org.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Caden Kinard
XPRIZE
949.280.0182

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Braun Launches the Next Generation of Electric Shaver With Braun NEVO Introducing a New Dawn of Smooth Touch2.7.2026 09:00:00 EEST | Press release

With over 100 years of exceptional German craftsmanship, Braun introduces Braun NEVO, an electric shaver redefining what a close shave and smooth skin mean. Every element has been reimagined: the sleek unibody stainless steel handle, the revolutionary AeroTouch™ Technology and advanced personalized display deliver a perfectly close shave without sacrificing comfort. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701842080/en/ Braun NEVO Shaver Oliver Grabes, Braun Head of Design, said: “At Braun, we set out to reimagine the shaving experience which led to the development of AeroTouch™ Shaving Technology, a cutting system engineered for ultra-low friction on the skin and high efficiency. This makes Braun NEVO our best shaver* setting a new standard for smooth skin.” Introducing the revolutionary world’s first AeroTouch™ Technology, featuring 250 diamond-sharp cutting edges and an exclusive Ultra gliding foil for a smooth g

Brenus Pharma Strengthens Its Governance With Designation of a New President and Appointment of Former Novo Nordisk EVP as Independent Member2.7.2026 09:00:00 EEST | Press release

Brenus Pharma, today announced key appointments to its board of directors. The company welcomes Eric DESSERTENNE, as President & Chairman of the board, succeeding co-founder Jacques GARDETTE, who will remain an active board member. Eric brings extensive experience in healthcare innovation and value creation, having notably led BIOCORP through its development and acquisition by Novo Nordisk. Brenus also appoints Camilla SYLVEST, as a second independent director, following the earlier addition of Diala EZZEDDINE a seasoned US-based biotech executive and entrepreneur. Camilla SYLVEST is an experienced pharmaceutical executive and global business leader, having spent nearly three decades at Novo Nordisk A/S, where she most recently served as Executive Vice President for Global Commercial Strategy, Corporate Communication and Sustainability. She currently serves on the Boards of Argenx SE, Getinge AB, and Zealand Pharma A/S, and has previously served on the Board of Danish Crown A/S and as

Access Advance and Alibaba Announce Alibaba's Expanded Participation in the VDP Pool2.7.2026 03:00:00 EEST | Press release

Access Advance LLC and Alibaba Group today announced that Alibaba has joined the Access Advance Video Distribution Patent Pool (VDP Pool) as a Licensee, securing a license to the pool's comprehensive coverage of HEVC, VVC, VP9, and AV1 codec technologies. The announcement marks a milestone in a multi-year collaboration between the two companies that spans the VVC Advance Patent Pool, where Alibaba participates as both a Licensor and Licensee, and the VDP Pool, where Alibaba joined as a Licensor in 2025. Alibaba's subsidiary Youku, one of China's leading streaming platforms, also joined the VDP Pool as a Licensee in 2025. Alibaba operates one of the world's most diverse video ecosystems, spanning a wide range of video-based services across e-commerce, entertainment, and digital media. As video has become central to how consumers shop, communicate, and access entertainment, the breadth of Alibaba's video operations reflects the kind of business model complexity the VDP Pool was designed

Vertex Announces US FDA Approval for Expanded Use of CASGEVY ® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia2.7.2026 02:58:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that the U.S. Food and Drug Administration (FDA) has approved expanded use of CASGEVY® (exagamglogene autotemcel) for the treatment of people ages 2 years and older with either sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) or transfusion-dependent beta thalassemia (TDT). CASGEVY is the first approved genetic therapy indicated for children as young as 2 years for both SCD and TDT. “Just as we redefined what is possible in cystic fibrosis, our ambition is to transform the future for people living with sickle cell disease and transfusion-dependent beta thalassemia. The remarkable consistency of results across age groups reinforces the potential of CASGEVY to deliver durable, transformative benefits to those who have historically had limited options,” said Reshma Kewalramani, M.D., Chief Executive Officer and President, Vertex. “We’re deeply grateful to the patients, families and investigators who pa

Robinhood Chooses Morpho to Power New Earn Product1.7.2026 22:15:00 EEST | Press release

Morpho, the open blockchain-based credit network, today announced it will power Robinhood’s new Earn product, enabling Robinhood's millions of eligible users more options to earn yield onchain via a self-custody wallet, directly within the Robinhood app. The product will roll out progressively to Robinhood's US customer base over the coming weeks. The Robinhood Earn product aims to provide risk-adjusted yield on idle balances using USDG, a dollar-pegged stablecoin. Morpho serves as the underlying credit network, Steakhouse Financial curates the vault infrastructure supporting the product, and Robinhood Chain acts as the settlement layer. The product is delivered through a seamless experience in the Robinhood app. Morpho operates as an open network on the blockchain. Lenders and borrowers compete in real time, helping create more efficient markets and enabling financial products with better rates and terms for users. USDG supplied through Robinhood Earn is deposited into a Morpho Vault

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye